Posted in Other

Here’s where Cramer stands at DuPont after key spin-off updates and guidance

DuPont shares remained flat on Thursday despite positive developments regarding the company’s spinoff plans. Jim Cramer sees more opportunity here. The news management said late…

Continue Reading Here’s where Cramer stands at DuPont after key spin-off updates and guidance
Posted in Other

Stocks appear on cool inflation, hot bank earnings – plus, new rules on biotech exports to China

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch – an actionable afternoon update, just in time for the final hour of…

Continue Reading Stocks appear on cool inflation, hot bank earnings – plus, new rules on biotech exports to China
Posted in Other

Danaher had a disappointing 2024. His path to success next year goes through Wall Street

Life sciences firm Danaher certainly hasn’t been an easy stock to own this year. A wave of startups going public on Wall Street would go…

Continue Reading Danaher had a disappointing 2024. His path to success next year goes through Wall Street